What is Blood Pressure Maintenance Supplements Market?
Hypertension is the most common condition and can go undetected for years and be considered the leading cause of premature death. Blood pressure is the force that blood exerts on the walls of the arteries, the blood vessels that carry oxygenated blood from the heart to the body. The pressure above 140/90 mmHg causes high blood pressure (or high blood pressure). According to the World Health Organization (WHO), around one in five adults worldwide lives with high blood pressure, and estimates the total population at 1.13 billion. Most people in low and middle-income regions are expected to drive the market for nutritional supplements to help maintain blood pressure. Many people prefer supplements that help maintain or avoid blood pressure along with medication. The COVID-19 outbreak has put tremendous pressure on health services. The increasing awareness of healthy eating among regional governments in the COVID-19 pandemic situation could lead to significant growth in the market for nutritional supplements for maintaining blood pressure. The market for nutritional supplements for maintaining blood pressure during the COVID-19 outbreak is expected to see positive growth due to patients' preference to minimize the symptomatic risk associated with novel coronavirus infections. Globally, the market for nutritional supplements for maintaining blood pressure is primarily driven by increasing signs of high blood pressure leading to heart complications, stroke, kidney failure, and blindness. Public awareness of the complications related to high blood pressure is one of the main factors fueling the growth of the market through the maintenance of blood pressure supplementation. Conversely, the surge in research related to the market for nutritional supplements to maintain blood pressure is expected to offer lucrative opportunities over the forecast period.
Highlights from Blood Pressure Maintenance Supplements Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Pfizer Inc. (United States), Novartis International AG (Switzerland), Abbot Laboratories (United States), The Carlyle Group (United States), Johnsons & Johnson (United States), GlaxoSmithKline Plc. (United Kingdom), Amway (United States), Bayer AG (Germany), Glanbia Nutritionals (NA) Inc. (United States) and Herbalife International (United States) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Pressure Maintenance Supplements market throughout the forecasted period.
Pfizer Inc. (United States), Novartis International AG (Switzerland), Abbot Laboratories (United States), The Carlyle Group (United States), Johnsons & Johnson (United States), GlaxoSmithKline Plc. (United Kingdom), Amway (United States), Bayer AG (Germany), Glanbia Nutritionals (NA) Inc. (United States) and Herbalife International (United States) are some of the key players profiled in the study. Blood Pressure Maintenance Supplements Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Adults, Pregnant Women and Geriatrics |
Distribution Channel | Hospital Pharmacies,Retail Pharmacies,Drugstores,Online Pharmacies |
Form | Tablets,Capsules,Softgel,Extracts,Liquids,Others |
Ingredients | Essential Minerals,Mineral,Fiber,Folic acid,Vitamins,Probiotics,Omega-3,Others |
On the basis of geography, the market of Blood Pressure Maintenance Supplements has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
The increasing Incidence of Hypertension has led to a Rising Demand for Cost-Effective, Rapid, and Accurate Diagnostic Solutions and Rising Awareness about Mental Health
Market Growth Drivers:
Rising Geriatric Population Affected by Blood Pressure Problems, Rapid Urbanization and Globalization Leading to Human Health Being Adversely Affected and Change In Lifestyle and Elevated Stress Levels
Challenges:
Availability of Alternative Therapies
Restraints:
False Claims and Negative Publicity about the Product
Opportunities:
Huge Funding In R&D and Various Initiatives by Government and Growing Improvements and Developments across the Healthcare Industry
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Blood Pressure Maintenance Supplements, Venture Capitalists and Private Equity Firms and End-Use Industry